India's Lupin gains after US FDA nod for Phytonadione Injectable Emulsion
09/10/2026 06:10
BUZZ-India's Lupin gains after US FDA nod for Phytonadione Injectable Emulsion
** Shares of Lupin LUPN.NS rise 1.5% to 1,966 rupees
** Pharmaceuticals co gets US FDA Approval for Phytonadione Injectable Emulsion, USP
** Phytonadione Injectable Emulsion is indicated for treatment of low blood clotting and vitamin K deficiency
** YTD, LUPN down 7% vs 14% gain in Nifty Pharma index .NIPHARM
(Reporting by Vijay Malkar)
Recent news on Lupin
See all newsIndia's Lupin gains after US FDA nod for Phytonadione Injectable Emulsion
Brief: Lupin Receives U.S. FDA Approval For Phytonadione Injectable Emulsion
Brief: Lupin Announces Completion Of Buyback Of Shares By Multicare Pharmaceuticals Philippines
Brief: Lupin Receives Tentative U.S. FDA Approval For Apixaban Oral Suspension 1.25Mg/Ml Via 505(B)(2)
Lupin may pursue deals worth up to $2 billion, Nomura says